Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Gossamer Bio Inc
About GOSS
Gossamer Bio, Inc. is a late-stage, clinical biopharmaceutical company, which is focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Seralutinib, also known as GB002, is an investigational inhaled, small-molecule, platelet-derived growth factor receptor (PDGFR), colony-stimulating factor 1 receptor (CSF1R), and c-KIT inhibitor, being evaluated in a Phase III clinical trial for the treatment of PAH. Seralutinib is designed to target the mechanisms that underlie pulmonary hypertension and to be delivered to the site of disease, via dry powder inhaler. Seralutinib is being evaluated in a Phase III clinical trial for the treatment of pulmonary arterial hypertension (PAH). Inhaled seralutinib, which is designed to act on both isoforms of the PDGFR, α and β, as well as the CSF1R and c-KIT pathways.
Find out what a historical investment in Gossamer Bio Inc would be worth today using our GOSS stock calculator.
Market Capitalisation
$46.73M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
15.58M
High today
$0.22
Low today
$0.20
Open price
$0.20
52-week high
$3.87
52-week low
$0.16
Ready to start your investing journey with Stake?
Open an accountHow do I buy GOSS shares in Australia?
Buying GOSS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Gossamer Bio Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in GOSS
What is the ticker symbol of Gossamer Bio Inc?
The ticker symbol for Gossamer Bio Inc is GOSS.
How much is one share of GOSS?
One share of GOSS is valued at $0.21 as of 20 May 2026.
What is the market capitalisation of Gossamer Bio Inc GOSS?
As of 20 May 2026 Gossamer Bio Inc has a market cap of $46.73M.
What is the 52-week high for Gossamer Bio Inc stock?
The Gossamer Bio Inc 52-week high stock price is $3.87.
What is the 52-week low for Gossamer Bio Inc stock?
The Gossamer Bio Inc 52-week low stock price is $0.16.
Can I buy GOSS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy GOSS shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in GOSS on Stake
- Buy GOSS from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of GOSS from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
GOSS related stocks